442 related articles for article (PubMed ID: 30201051)
1. TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study.
de Vries PJ; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; Dahlin M; D'Amato L; d'Augères GB; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Kingswood JC; Lawson JA; Macaya A; Marques R; Nabbout R; O'Callaghan F; Qin J; Sander V; Sauter M; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen AC;
Orphanet J Rare Dis; 2018 Sep; 13(1):157. PubMed ID: 30201051
[TBL] [Abstract][Full Text] [Related]
2. Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders (TAND): New Findings on Age, Sex, and Genotype in Relation to Intellectual Phenotype.
de Vries PJ; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; Dahlin M; D'Amato L; Beaure d'Augères G; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Marques R; Nabbout R; O'Callaghan F; Qin J; Sander V; Sauter M; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Kingswood JC; Jansen AC;
Front Neurol; 2020; 11():603. PubMed ID: 32733359
[No Abstract] [Full Text] [Related]
3. The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1.
Cervi F; Saletti V; Turner K; Peron A; Bulgheroni S; Taddei M; La Briola F; Canevini MP; Vignoli A
Orphanet J Rare Dis; 2020 Sep; 15(1):237. PubMed ID: 32894194
[TBL] [Abstract][Full Text] [Related]
4. Is It Feasible to Identify Natural Clusters of TSC-Associated Neuropsychiatric Disorders (TAND)?
Leclezio L; Gardner-Lubbe S; de Vries PJ
Pediatr Neurol; 2018 Apr; 81():38-44. PubMed ID: 29530301
[TBL] [Abstract][Full Text] [Related]
5. Natural clusters of tuberous sclerosis complex (TSC)-associated neuropsychiatric disorders (TAND): new findings from the TOSCA TAND research project.
de Vries PJ; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; D'Amato L; Beure d'Augères G; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Marques R; Nabbout R; O'Callaghan F; Qin J; Sander V; Sauter M; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Kingswood JC; Jansen AC;
J Neurodev Disord; 2020 Sep; 12(1):24. PubMed ID: 32873244
[TBL] [Abstract][Full Text] [Related]
6. Epilepsy and Neurodevelopmental Comorbidities in Tuberous Sclerosis Complex: A Natural History Study.
Gupta A; de Bruyn G; Tousseyn S; Krishnan B; Lagae L; Agarwal N;
Pediatr Neurol; 2020 May; 106():10-16. PubMed ID: 32139167
[TBL] [Abstract][Full Text] [Related]
7. A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND).
de Vries PJ; Wilde L; de Vries MC; Moavero R; Pearson DA; Curatolo P
Am J Med Genet C Semin Med Genet; 2018 Sep; 178(3):309-320. PubMed ID: 30117265
[TBL] [Abstract][Full Text] [Related]
8. [Neuropsychiatric manifestations in Tuberous Sclerosis Complex (TSC): diagnostic guidelines, TAND concept and therapy with mTOR inhibitors].
Waltereit R; Feucht M; de Vries MC; Huemer J; Roessner V; de Vries PJ
Z Kinder Jugendpsychiatr Psychother; 2019 Mar; 47(2):139-153. PubMed ID: 30080117
[TBL] [Abstract][Full Text] [Related]
9. TuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patients.
Kingswood JC; d'Augères GB; Belousova E; Ferreira JC; Carter T; Castellana R; Cottin V; Curatolo P; Dahlin M; de Vries PJ; Feucht M; Fladrowski C; Gislimberti G; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Nabbout R; O'Callaghan F; Benedik MP; Qin J; Marques R; Sander V; Sauter M; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen AC;
Orphanet J Rare Dis; 2017 Jan; 12(1):2. PubMed ID: 28057044
[TBL] [Abstract][Full Text] [Related]
10. Tuberous sclerosis-associated neuropsychiatric disorders: a paediatric cohort study.
Toldo I; Brasson V; Miscioscia M; Pelizza MF; Manara R; Sartori S; Mantegazza G; Vecchi M; Nosadini M; Gatta M
Dev Med Child Neurol; 2019 Feb; 61(2):168-173. PubMed ID: 30298907
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for the development of autism spectrum disorder in children with tuberous sclerosis complex: protocol for a systematic review.
Mitchell R; Barton S; Harvey AS; Williams K
Syst Rev; 2017 Mar; 6(1):49. PubMed ID: 28270230
[TBL] [Abstract][Full Text] [Related]
12. Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA).
Sauter M; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; Dahlin M; D'Amato L; d'Augères GB; de Vries PJ; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Marques R; Nabbout R; O'Callaghan F; Qin J; Sander V; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen A; Kingswood JC;
Orphanet J Rare Dis; 2021 Jul; 16(1):301. PubMed ID: 34229737
[TBL] [Abstract][Full Text] [Related]
13. Self-injury and aggression in adults with tuberous sclerosis complex: Frequency, associated person characteristics, and implications for assessment.
Wilde L; Eden K; de Vries P; Moss J; Welham A; Oliver C
Res Dev Disabil; 2017 May; 64():119-130. PubMed ID: 28411579
[TBL] [Abstract][Full Text] [Related]
14. Autism spectrum disorder in tuberous sclerosis complex: searching for risk markers.
Vignoli A; La Briola F; Peron A; Turner K; Vannicola C; Saccani M; Magnaghi E; Scornavacca GF; Canevini MP
Orphanet J Rare Dis; 2015 Dec; 10():154. PubMed ID: 26631248
[TBL] [Abstract][Full Text] [Related]
15. Tuberous Sclerosis Complex in Chinese patients: Phenotypic analysis and mutational screening of TSC1/TSC2 genes.
Lin S; Zeng JB; Zhao GX; Yang ZZ; Huang HP; Lin MT; Wu ZY; Wang N; Chen WJ; Fang L
Seizure; 2019 Oct; 71():322-327. PubMed ID: 31525612
[TBL] [Abstract][Full Text] [Related]
16. The research landscape of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)-a comprehensive scoping review.
Vanclooster S; Bissell S; van Eeghen AM; Chambers N; De Waele L; Byars AW; Capal JK; Cukier S; Davis P; Flinn J; Gardner-Lubbe S; Gipson T; Heunis TM; Hook D; Kingswood JC; Krueger DA; Kumm AJ; Sahin M; Schoeters E; Smith C; Srivastava S; Takei M; Waltereit R; Jansen AC; de Vries PJ
J Neurodev Disord; 2022 Feb; 14(1):13. PubMed ID: 35151277
[TBL] [Abstract][Full Text] [Related]
17. Assessment of tuberous sclerosis-associated neuropsychiatric disorders using the MINI-KID tool: a pediatric case-control study.
Ding Y; Wang J; Zhou H; Li T; Zhou S; Wang Y
Orphanet J Rare Dis; 2021 Apr; 16(1):181. PubMed ID: 33865427
[TBL] [Abstract][Full Text] [Related]
18. Tuberous Sclerosis Complex Patients' Needs and Difficulties-Results of TAND Questionnaire Analysis in Polish Adult Population.
Marcinkowska AB; Jóźwiak S; Tarasewicz A; Dębska-Ślizień A; Szurowska E
J Clin Med; 2022 Nov; 11(21):. PubMed ID: 36362764
[TBL] [Abstract][Full Text] [Related]
19. The association of neurodevelopmental abnormalities, congenital heart and renal defects in a tuberous sclerosis complex patient cohort.
Robinson J; Uzun O; Loh NR; Harris IR; Woolley TE; Harwood AJ; Gardner JF; Syed YA
BMC Med; 2022 Apr; 20(1):123. PubMed ID: 35440050
[TBL] [Abstract][Full Text] [Related]
20. Tuberous sclerosis: a review of the past, present, and future.
Uysal SP; Şahin M
Turk J Med Sci; 2020 Nov; 50(SI-2):1665-1676. PubMed ID: 32222129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
